Stephen Feider's most recent trade in Beta Bionics Inc. was a trade of 6,675 Common Stock done at an average price of $19.1 . Disclosure was reported to the exchange on Sept. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.11 per share. | 02 Sep 2026 | 6,675 | 159,378 | - | 19.1 | 127,580 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.05 per share. | 26 Jun 2026 | 5,104 | 165,931 | - | 17.0 | 87,006 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 26 Jun 2026 | 5,104 | 171,157 | - | 5.1 | 26,030 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | 26 Jun 2026 | 5,104 | 44,591 | - | - | Employee Stock Option (right to buy) | ||
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.05 per share. | 26 Jun 2026 | 5,104 | 166,053 | - | 17.0 | 87,006 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 26 Jun 2026 | 4,982 | 171,035 | - | 5.1 | 25,408 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | 26 Jun 2026 | 4,982 | 44,713 | - | - | Employee Stock Option (right to buy) | ||
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | 26 Jun 2026 | 4,896 | 39,817 | - | - | Employee Stock Option (right to buy) | ||
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 26 Jun 2026 | 4,896 | 165,931 | - | 17.0 | 83,381 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 26 Jun 2026 | 4,896 | 170,827 | - | 5.1 | 24,970 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | 26 Jun 2026 | 4,896 | 39,695 | - | - | Employee Stock Option (right to buy) | ||
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 26 Jun 2026 | 4,896 | 166,053 | - | 17.0 | 83,381 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 26 Jun 2026 | 4,896 | 170,949 | - | 5.1 | 24,970 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.61 per share. | 02 Jun 2026 | 6,676 | 166,053 | - | 12.6 | 84,165 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 131,543 | 174,157 | - | 0 | Common Stock | |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | 27 Feb 2026 | 110,342 | 110,342 | - | - | Employee Stock Option (right to buy) | ||
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | 27 Feb 2026 | 70,831 | 70,831 | - | - | Employee Stock Option (right to buy) | ||
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.36 per share. | 27 Feb 2026 | 1,428 | 172,729 | - | 12.4 | 17,652 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 02 Jan 2026 | 20,000 | 62,614 | - | 5.1 | 102,000 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 29.53 per share. | 02 Jan 2026 | 20,000 | 42,614 | - | 29.5 | 590,680 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | 02 Jan 2026 | 20,000 | 49,695 | - | - | Employee Stock Option (right to buy) | ||
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 29.34 per share. | 02 Dec 2025 | 1,427 | 42,614 | - | 29.3 | 41,862 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 03 Oct 2025 | 4,982 | 49,023 | - | 5.1 | 25,408 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | 03 Oct 2025 | 4,982 | 69,695 | - | - | Employee Stock Option (right to buy) | ||
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.52 per share. | 03 Oct 2025 | 3,828 | 45,195 | - | 21.5 | 82,368 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.28 per share. | 03 Oct 2025 | 1,154 | 44,041 | - | 22.3 | 25,709 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | 01 Oct 2025 | 15,018 | 74,677 | - | - | Employee Stock Option (right to buy) | ||
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 01 Oct 2025 | 15,018 | 59,059 | - | 5.1 | 76,592 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.76 per share. | 01 Oct 2025 | 14,918 | 44,141 | - | 20.8 | 309,698 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.08 per share. | 01 Oct 2025 | 100 | 44,041 | - | 21.1 | 2,108 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 08 Sep 2025 | 9,900 | 53,941 | - | 5.1 | 50,490 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | 08 Sep 2025 | 9,900 | 89,695 | - | - | Employee Stock Option (right to buy) | ||
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.13 per share. | 08 Sep 2025 | 9,900 | 44,041 | - | 21.1 | 209,151 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 05 Sep 2025 | 100 | 44,141 | - | 5.1 | 510 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | 05 Sep 2025 | 100 | 99,595 | - | - | Employee Stock Option (right to buy) | ||
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.00 per share. | 05 Sep 2025 | 100 | 44,041 | - | 21 | 2,100 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.86 per share. | 02 Sep 2025 | 1,462 | 44,041 | - | 18.9 | 27,578 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | 22 Aug 2025 | 4,413 | 99,695 | - | - | Employee Stock Option (right to buy) | ||
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.01 per share. | 22 Aug 2025 | 4,413 | 45,503 | - | 17.0 | 75,083 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 22 Aug 2025 | 4,413 | 49,916 | - | 5.1 | 22,506 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | 19 Aug 2025 | 5,587 | 104,108 | - | - | Employee Stock Option (right to buy) | ||
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 19 Aug 2025 | 5,587 | 51,090 | - | 5.1 | 28,494 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 19 Aug 2025 | 5,587 | 45,503 | - | 17.0 | 95,172 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.15 per share. | 02 Jun 2025 | 951 | 45,639 | - | 18.1 | 17,260 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 02 Jun 2025 | 410 | 46,590 | - | 17.0 | 6,981 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.69 per share. | 02 Jun 2025 | 136 | 45,503 | - | 18.7 | 2,542 | Common Stock |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | 27 Feb 2025 | 71,000 | 71,000 | - | - | Employee Stock Option (right to buy) | ||
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 47,000 | 47,000 | - | 0 | Common Stock | |
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | 31 Jan 2025 | 186,203 | 186,203 | - | - | Employee Stock Option (right to buy) | ||
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | 31 Jan 2025 | 166,542 | 166,542 | - | - | Employee Stock Option (right to buy) | ||
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | 31 Jan 2025 | 109,695 | 109,695 | - | - | Employee Stock Option (right to buy) | ||
| Beta Bionics Inc | Mr. Stephen Feider | Chief Financial Officer | 29 Jan 2025 | 186,203 | 186,203 | - | - | Employee Stock Option (right to buy) |